Abstract
A microwave assisted multi-component reaction involving 2-amino-1,3,4-thiadiazoles, aromatic aldehydes and thioglycolic acid as substrates, afforded a series of novel 2-(1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones in good yields.
Keywords: 4-Thiazolidinones, microwave irradiation, synthesis.
Graphical Abstract
Letters in Organic Chemistry
Title:Microwave Assisted One-pot Three Component Synthesis of Novel 2-(5- Aryloxymethyl-1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones
Volume: 12 Issue: 2
Author(s): Guoli Huang, Bo Liu, Mingyu Teng and Yegao Chen
Affiliation:
Keywords: 4-Thiazolidinones, microwave irradiation, synthesis.
Abstract: A microwave assisted multi-component reaction involving 2-amino-1,3,4-thiadiazoles, aromatic aldehydes and thioglycolic acid as substrates, afforded a series of novel 2-(1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones in good yields.
Export Options
About this article
Cite this article as:
Huang Guoli, Liu Bo, Teng Mingyu and Chen Yegao, Microwave Assisted One-pot Three Component Synthesis of Novel 2-(5- Aryloxymethyl-1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones, Letters in Organic Chemistry 2015; 12 (2) . https://dx.doi.org/10.2174/1570178612666141211224809
DOI https://dx.doi.org/10.2174/1570178612666141211224809 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers
Current Medicinal Chemistry Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery Recent Advances in the Medicinal Chemistry of Aurones
Current Medicinal Chemistry Apoptotic Effects of Melittin on 4T1 Breast Cancer Cell Line is associated with Up Regulation of Mfn1 and Drp1 mRNA Expression
Anti-Cancer Agents in Medicinal Chemistry Metabolomics of Serum Peptides
Protein & Peptide Letters Mechanisms of Interferon Mediated Anti-Viral Resistance
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Current Gene Therapy Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer
Current Protein & Peptide Science Molecular Docking Analysis of Flavonoid Compounds with Matrix Metalloproteinase- 8 for the Identification of Potential Effective Inhibitors
Letters in Drug Design & Discovery Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Cerium(III) and Neodymium(III) Complexes as Scavengers of X/XODerived Superoxide Radical
Medicinal Chemistry The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of <sup>99m</sup>Tc Labeled Paclitaxel: In Vitro Monitoring in Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Natural Products As Antimitotic Agents
Current Topics in Medicinal Chemistry Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway
Current Cancer Therapy Reviews Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias
Current Cancer Drug Targets Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Matrix Metalloproteinases
Current Medicinal Chemistry Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme
Current Pharmaceutical Design